✦ LIBER ✦

Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells

✍ Scribed by Juan P. Arnoletti; Daniel Albo; Mark S. Granick; Mark P. Solomon; Analia Castiglioni; Vicki L. Rothman; George P. Tuszynski

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 860 KB
Volume: 76
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950915)76:6<998::aid-cncr2820760613>3.0.co;2-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transforming growth factor β1, urokinase

Transforming growth factor β1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa

✍ Fatima S. Pasini; M. Mitzi Brentani; Luiz P. Kowalski; Miriam H. H. Federico 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Background: A balance between urokinase-type plasminogen activator (upa) and its main inhibitor type-1 (pai-1) appears to be important for cancer invasive behavior. since upa/pai-1 system seems to be regulated by transforming growth factor beta1 (tgfbeta1) in different cell types, our aim was to

Transforming growth factor β-1 and amphi

Transforming growth factor β-1 and amphiregulin act in synergy to increase the production of urokinase-type plasminogen activator in transformed breast epithelial cells

✍ Corinne Giusti; Sylvie Desruisseau; Lin Ma; Fabien Calvo; Pierre-Marie Martin; Y 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 276 KB 👁 1 views

## Abstract Amphireguline (AR) is an epidermal growth factor (EGF)‐related peptide that seems to play an important role in breast cancer progression. We have demonstrated recently that suppression of AR expression in transformed breast epithelial cells considerably reduced both size and neovascular

Transforming growth factor-β1 enhances t

Transforming growth factor-β1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity

✍ Antonietta R. Farina; Anna Coppa; Antonella Tiberio; Antonella Tacconelli; Aless 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 201 KB 👁 1 views

Transforming growth factor-beta (TGF␤1) enhances human MDA-MB-231 breast tumour cell invasion of reconstituted basement membrane in vitro but does not inhibit proliferation of this cell line. In contrast to basal invasion, which is plasmin-, urokinase (uPA)-, tissue-type plasminogen activator (t-PA)

The insulin-like growth factor-1 elevate

The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: A new avenue for breast cancer therapy

✍ S.E. Dunn; J.V. Torres; N. Nihei; J.C. Barrett 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

Tumor recurrence is a common problem in the treatment of breast cancer. In breast cancer, the expression of high protein levels of the insulin-like growth factor-1 receptor (IGF-1R) and urokinase-type plasminogen activator-1 (uPA) is strongly associated with breast cancer recurrence and decreased su

Urokinase-type-plasminogen-activator(UPA

Urokinase-type-plasminogen-activator(UPA) production by human breast (myo)fibroblasts in vitro: Influence of transforming growth factor-β1 (TGFβ1) compared with factor(s) released by human epithelial-carcinoma cells

✍ Anieta M. Sieuwerts; Jan G. M. Klijn; Sonja C. Henzen-Logmans; Ivo Bouwman; Kees 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 112 KB 👁 1 views

Growth state-dependent regulation of pla

Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-β1

✍ Jeffrey R. Boehm; Stacie M. Kutz; E. Helene Sage; Lisa Staiano-Coico; Paul J. Hi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 1 views

Transit of serumstimulated normal rat kidney (NRK) epthelial cells through the first division cycle after release from quiescence (G 0 ) provided a model system to assess the kinetics and mechanisms underlying PAI-1 expression in a growth "activated" phenotype. PAI-1 mRNA transcripts increased by mo